Name of the product: POTEKAM

Active ingredient: Topotekan 4 mg

Dosage form: lyophilised injection

Dispensing requirements: Rx only

Argentine Industry

Composition:

Each glass bottle contains topotecan 4 mg (as topotecan hydrochloride), mannitol and tartaric acid.

Indications:

POTEKAM is indicated for the treatment of patients with metastasic ovarian carcinoma after the inicial or subsequent chemotherapy has failed.

Therapeutic action:

Antineoplastic.

Storage:

Keep between 20º - 25º C, in the marketed packing. Protect from the light.

Marketed presentations:

Packs containing 5 glass bottles.

Packs containing 50 and 100 glass bottles, for use in hospitals.

Medicinal speciality authorised by the Ministry of Health.

Certificate Nº 47545

Laboratorio DOSA S.A.

Girardot 1369, (C1427AKC) Buenos Aires, Argentine

Pharmaceutical Director: María C. Terzo, Pharmacist